MX356443B - Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo. - Google Patents

Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Info

Publication number
MX356443B
MX356443B MX2013014605A MX2013014605A MX356443B MX 356443 B MX356443 B MX 356443B MX 2013014605 A MX2013014605 A MX 2013014605A MX 2013014605 A MX2013014605 A MX 2013014605A MX 356443 B MX356443 B MX 356443B
Authority
MX
Mexico
Prior art keywords
recrystallised
dehydrated
enrofloxacin
producing same
hydrochloride complex
Prior art date
Application number
MX2013014605A
Other languages
English (en)
Other versions
MX2013014605A (es
Inventor
Salvador Sumano López Héctor
Gutiérrez Olvera Lilia
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2013014605A priority Critical patent/MX356443B/es
Priority to PCT/MX2014/000192 priority patent/WO2015088305A1/es
Publication of MX2013014605A publication Critical patent/MX2013014605A/es
Publication of MX356443B publication Critical patent/MX356443B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se describe un complejo recristalizado de clorhidrato de enrofloxacina dihidratado que tiene la fórmula (I): (ver Fórmula) en donde la recristalización ácida y formación de complejos con cloro, magnesio y sulfato producen un complejo de clorhidrato de enrofloxacina recristalizado de alta solubilidad, lo cual brinda por vía subcutánea concentraciones séricas máximas (Cmax) y áreas bajo la curva (AUC) de concentración vs. tiempo mayores que las logradas con la enrofloxacina base.
MX2013014605A 2013-12-11 2013-12-11 Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo. MX356443B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013014605A MX356443B (es) 2013-12-11 2013-12-11 Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.
PCT/MX2014/000192 WO2015088305A1 (es) 2013-12-11 2014-12-03 Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013014605A MX356443B (es) 2013-12-11 2013-12-11 Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Publications (2)

Publication Number Publication Date
MX2013014605A MX2013014605A (es) 2015-06-11
MX356443B true MX356443B (es) 2018-05-21

Family

ID=53371519

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014605A MX356443B (es) 2013-12-11 2013-12-11 Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Country Status (2)

Country Link
MX (1) MX356443B (es)
WO (1) WO2015088305A1 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10328666A1 (de) * 2003-06-26 2005-01-13 Bayer Healthcare Ag Tabletten enthaltend Geschmacks-und/oder Aromastoffe
WO2010123337A1 (es) * 2009-04-24 2010-10-28 Weisepharm S.A De C.V Complejo de enrofloxacina con máximo tiempo de residencia en plasma de mamíferos y aves
CN103211818B (zh) * 2012-01-18 2015-07-22 洛阳惠中兽药有限公司 一种治疗或预防家畜细菌性和支原体疾病的药物组合物及其用途

Also Published As

Publication number Publication date
MX2013014605A (es) 2015-06-11
WO2015088305A1 (es) 2015-06-18

Similar Documents

Publication Publication Date Title
JOP20200225A1 (ar) مشتق كوينولين عالي النقاء وطريقة لإنتاجه
MY167697A (en) Method for producing 4,4-difluoro-3,4- dihydroisoquinoline derivatives
TN2014000138A1 (en) Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
EA201692150A1 (ru) Способ лечения аденокарциномы легкого
MY177913A (en) Process for preparing alkanesulfonic acids
NZ711192A (en) Process for making benzoxazepin compounds
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
EA201690269A1 (ru) Способы контроля уровней фукозилирования в белках
MX2015006407A (es) Procedimiento de preparacion de albumina humana con nivel de oxigeno disuelto reducido.
EA201171466A1 (ru) Композиция неслеживающейся соли, способ ее получения и использование
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof
MX2016016479A (es) Metodo para producir un pentapeptido sintetico.
MX2016004967A (es) Tratamiento para cancer pancreatico.
PH12016500913A1 (en) Soap bar
PL405540A1 (pl) Sposób otrzymywania ksantohumolu
MX2019001228A (es) Metodo de produccion del compuesto de pirazol-amida.
UA113988C2 (xx) Спосіб стабілізації бета-напівгідрату штукатурного гіпсу
SG10201901578UA (en) Processes for the preparation of pyrimidinylcyclopentane compounds
EA033071B1 (ru) Способ увеличения выхода продуктов из ацетолактата
MX356443B (es) Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.
UA117560C2 (uk) Стабілізація водного розчину органічної солі заліза
NZ715554A (en) Method of treating hypertrophic cardiomyopathy
EA201592221A1 (ru) Способ получения ивабрадина
MX2015008354A (es) Proceso para la preparacion de derivados de 4-metilpent-3-en-1-ol.
MX2015012610A (es) Pacritinib deuterizado.

Legal Events

Date Code Title Description
FG Grant or registration